Frank Boschelli
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Quinazolinone synthesis and applications, Synthesis and biological activity, Chronic Lymphocytic Leukemia Research, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.(2003)
- → Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants(2008)397 cited
- → In vitro and In vivo Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells(2006)368 cited
- → Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase Activity(2001)219 cited
- → SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells(2008)165 cited
- → A Src/Abl Kinase Inhibitor, SKI-606, Blocks Breast Cancer Invasion, Growth, and Metastasis In vitro and In vivo(2007)147 cited
- → SKI-606, a Src/Abl Inhibitor withIn vivoActivity in Colon Tumor Xenograft Models(2005)134 cited
- → Discovery of Benzisoxazoles as Potent Inhibitors of Chaperone Heat Shock Protein 90(2008)94 cited
- → Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles(2001)86 cited
- → CDC37 is required for p60v-src activity in yeast.(1996)73 cited